CONTENTS:
- A revised checklist for writing up research reports [Editorial]. West R., Marsden J., Humphreys K., Darke S., p. 1567-1570.
- Alcohol industry involvement in policymaking: a systematic review. McCambridge J., Mialon M., Hawkins B., p. 1571-1584.
- Perception of physical attractiveness when consuming and not consuming alcohol: a meta-analysis. Bowdring M.A., Sayette M.A., p. 1585-1597.
- Reducing the standard serving size of alcoholic beverages prompts reductions in alcohol consumption. Kersbergen I., Oldham M., Jones A., Field M., Angus C., Robinson E., p. 1598-1608.
- Texting to Reduce Alcohol Misuse (TRAM): main findings from a randomized controlled trial of a text message intervention to reduce binge drinking among disadvantaged men. Crombie I.K., Irvine L., Williams B., Sniehotta F.F., Petrie D., Jones C., et al., p. 1609-1618.
- Sexual-orientation differences in alcohol use trajectories and disorders in emerging adulthood: results from a longitudinal cohort study in the United States. Coulter R.W.S., Jun H.J., Calzo J.P., Truong N.L., Mair C., Markovic N., et al., p. 1619-1632.
- Sickness absence diagnoses among abstainers, low-risk drinkers and at-risk drinkers: consideration of the U-shaped association between alcohol use and sickness absence in four cohort studies. Ervasti J., Kivimäki M., Head J., Goldberg M., Airagnes G., Pentti J., et al., p. 1633-1642.
- Are changes in drinking related to changes in cannabis use among Swedish adolescents? A time-series analysis for the period 1989-2016. Gripe I., Danielsson A.K., Ramstedt M., p. 1643-1650.
- Effects of a prior authorization policy for extended-release/long-acting opioids on utilization and outcomes in a state Medicaid program. Keast S.L., Kim H., Deyo R.A., Middleton L., McConnell K.J., Zhang K., et al., p. 1651-1660.
- Testing associations between cannabis use and subcortical volumes in two large population-based samples. Gillespie N.A., Neale M.C., Bates T.C., Eyler L.T., Fennema-Notestine C., Vassileva J., et al., p. 1661-1672.
- An RCT with the combination of varenicline and bupropion for smoking cessation: clinical implications for front line use. Cinciripini P.M., Minnix J.A., Green C.E., Robinson J.D., Engelmann J.M., Versace F., et al., p. 1673-1682.
- A randomized controlled evaluation of the tobacco status project, a Facebook intervention for young adults. Ramo D.E., Thrul J., Delucchi K.L., Hall S., Ling P.M., Belohlavek A., et al., p. 1683-1695.
- Cannabidiol reverses attentional bias to cigarette cues in a human experimental model of tobacco withdrawal. Hindocha C., Freeman T.P., Grabski M., Stroud J.B., Crudgington H., Davies A.C., et al., p. 1696-1705.
- Does early exposure to caffeine promote smoking and alcohol use behavior? A prospective analysis of middle school students. Kristjansson A.L., Kogan S.M., Mann M.J., Smith M.L., Juliano L.M., Lilly C.L., et al., p. 1706-1713.
- Commentary on Kristjansson et al. (2018): Caffeine use during early adolescence as a possible risk factor for initiation of smoking and alcohol use. Treur J.L., Munafo M.R., p. 1714-1715.
- The safety, effectiveness and cost-effectiveness of cytisine in achieving six-month continuous smoking abstinence in tuberculosis patients - protocol for a double-blind, placebo-controlled randomized trial. Dogar O., Barua D., Boeckmann M., Elsey H., Fatima R., Gabe R., et al., p. 1716-1726.
- Impact of current and scaled-up levels of hepatitis C prevention and treatment interventions for people who inject drugs in three UK settings - what is required to achieve the WHO's HCV elimination targets? Ward Z., Platt L., Sweeney S., Hope V.D., Maher L., Hutchinson S., et al., p. 1727-1738.
- Keeping secrets: Leslie E. Keeley, the gold cure and the 19th-century neuroscience of addiction. Hickman T.A., p. 1739-1749.
- Non-pharmacological interventions for neonatal abstinence syndrome. Allen N., Prunty L., Babcock C.C.K., Attarabeen O., Patel I., p. 1750-1751.
- Encouraging smoking cessation in Ramadan in primary care. Mughal F., Kingstone T., p. 1751.
- The need for more research and considered debate regarding women-only treatment services: a comment on Neale et al. (2018). Day C.A., Coupland H., Moensted M., Burns L., p. 1752.